Association between SLC20A1 and sodium-lithium countertransport

Xiaojing Zheng, Alanna C. Morrison, Stephen T Turner, Robert E. Ferrell

Research output: Contribution to journalArticle

Abstract

BackgroundSodium-lithium countertransport (SLC) is a premorbidity marker of essential hypertension. Evidence from linkage analysis and kinetic studies in humans have suggested that SLC20A1 variations may affect SLC activity as measured in erythrocytes and leukocytes. SLC20A1 encodes a sodium-dependent phosphate cotransporter, and is widely expressed on the mammalian plasma membrane. In this study, we investigated the relationship between SLC20A1 and SLC activity.MethodsBy means of gene expression profiling, we studied the expressions of SLC20A1 in individuals with high SLC activity as compared to those with low SLC activity. In order to investigate the allelic association of SLC20A1 with SLC, we genotyped six tag single-nucleotide polymorphisms (tSNPs) in SLC20A1 in subjects from the Rochester Family Heart Study (RFHS) involving 1,815 individuals from 252 pedigrees of mixed European ancestry. The genetic association of SLC20A1 with SLC was assessed by Sequential Oligogenic Linkage Analysis Routines (SOLAR).ResultsExpression levels of SLC20A1 were higher in individuals with high SLC activity than in those with low SLC activity. Four SNPs in SLC20A1 were associated with SLC activity after adjusting for age, sex, body mass index, triglycerides, and antihypertensive drug treatment (P 0.05). The strongest evidence of association was in respect of rs4849091 (P = 0.001), and this association remained significant even after correction for multiple tests.ConclusionsAllelic variations in SLC20A1 were associated with the levels of SLC activity, thereby supporting the hypothesis that SLC20A1 is involved in determining SLC activity.

Original languageEnglish (US)
Pages (from-to)1069-1072
Number of pages4
JournalAmerican Journal of Hypertension
Volume24
Issue number10
DOIs
StatePublished - Oct 2011

Fingerprint

Lithium
Single Nucleotide Polymorphism
Sodium-Phosphate Cotransporter Proteins
Sodium
Gene Expression Profiling
Pedigree
Antihypertensive Agents
Triglycerides
Body Mass Index
Leukocytes
Erythrocytes
Cell Membrane
Essential Hypertension

Keywords

  • blood pressure
  • genetic association
  • hypertension
  • SLC20A1
  • sodium-lithium countertransport

ASJC Scopus subject areas

  • Internal Medicine

Cite this

Association between SLC20A1 and sodium-lithium countertransport. / Zheng, Xiaojing; Morrison, Alanna C.; Turner, Stephen T; Ferrell, Robert E.

In: American Journal of Hypertension, Vol. 24, No. 10, 10.2011, p. 1069-1072.

Research output: Contribution to journalArticle

Zheng, Xiaojing ; Morrison, Alanna C. ; Turner, Stephen T ; Ferrell, Robert E. / Association between SLC20A1 and sodium-lithium countertransport. In: American Journal of Hypertension. 2011 ; Vol. 24, No. 10. pp. 1069-1072.
@article{0559ba30208249f9b3399cf64c2a0dc2,
title = "Association between SLC20A1 and sodium-lithium countertransport",
abstract = "BackgroundSodium-lithium countertransport (SLC) is a premorbidity marker of essential hypertension. Evidence from linkage analysis and kinetic studies in humans have suggested that SLC20A1 variations may affect SLC activity as measured in erythrocytes and leukocytes. SLC20A1 encodes a sodium-dependent phosphate cotransporter, and is widely expressed on the mammalian plasma membrane. In this study, we investigated the relationship between SLC20A1 and SLC activity.MethodsBy means of gene expression profiling, we studied the expressions of SLC20A1 in individuals with high SLC activity as compared to those with low SLC activity. In order to investigate the allelic association of SLC20A1 with SLC, we genotyped six tag single-nucleotide polymorphisms (tSNPs) in SLC20A1 in subjects from the Rochester Family Heart Study (RFHS) involving 1,815 individuals from 252 pedigrees of mixed European ancestry. The genetic association of SLC20A1 with SLC was assessed by Sequential Oligogenic Linkage Analysis Routines (SOLAR).ResultsExpression levels of SLC20A1 were higher in individuals with high SLC activity than in those with low SLC activity. Four SNPs in SLC20A1 were associated with SLC activity after adjusting for age, sex, body mass index, triglycerides, and antihypertensive drug treatment (P 0.05). The strongest evidence of association was in respect of rs4849091 (P = 0.001), and this association remained significant even after correction for multiple tests.ConclusionsAllelic variations in SLC20A1 were associated with the levels of SLC activity, thereby supporting the hypothesis that SLC20A1 is involved in determining SLC activity.",
keywords = "blood pressure, genetic association, hypertension, SLC20A1, sodium-lithium countertransport",
author = "Xiaojing Zheng and Morrison, {Alanna C.} and Turner, {Stephen T} and Ferrell, {Robert E.}",
year = "2011",
month = "10",
doi = "10.1038/ajh.2011.130",
language = "English (US)",
volume = "24",
pages = "1069--1072",
journal = "American Journal of Hypertension",
issn = "0895-7061",
publisher = "Oxford University Press",
number = "10",

}

TY - JOUR

T1 - Association between SLC20A1 and sodium-lithium countertransport

AU - Zheng, Xiaojing

AU - Morrison, Alanna C.

AU - Turner, Stephen T

AU - Ferrell, Robert E.

PY - 2011/10

Y1 - 2011/10

N2 - BackgroundSodium-lithium countertransport (SLC) is a premorbidity marker of essential hypertension. Evidence from linkage analysis and kinetic studies in humans have suggested that SLC20A1 variations may affect SLC activity as measured in erythrocytes and leukocytes. SLC20A1 encodes a sodium-dependent phosphate cotransporter, and is widely expressed on the mammalian plasma membrane. In this study, we investigated the relationship between SLC20A1 and SLC activity.MethodsBy means of gene expression profiling, we studied the expressions of SLC20A1 in individuals with high SLC activity as compared to those with low SLC activity. In order to investigate the allelic association of SLC20A1 with SLC, we genotyped six tag single-nucleotide polymorphisms (tSNPs) in SLC20A1 in subjects from the Rochester Family Heart Study (RFHS) involving 1,815 individuals from 252 pedigrees of mixed European ancestry. The genetic association of SLC20A1 with SLC was assessed by Sequential Oligogenic Linkage Analysis Routines (SOLAR).ResultsExpression levels of SLC20A1 were higher in individuals with high SLC activity than in those with low SLC activity. Four SNPs in SLC20A1 were associated with SLC activity after adjusting for age, sex, body mass index, triglycerides, and antihypertensive drug treatment (P 0.05). The strongest evidence of association was in respect of rs4849091 (P = 0.001), and this association remained significant even after correction for multiple tests.ConclusionsAllelic variations in SLC20A1 were associated with the levels of SLC activity, thereby supporting the hypothesis that SLC20A1 is involved in determining SLC activity.

AB - BackgroundSodium-lithium countertransport (SLC) is a premorbidity marker of essential hypertension. Evidence from linkage analysis and kinetic studies in humans have suggested that SLC20A1 variations may affect SLC activity as measured in erythrocytes and leukocytes. SLC20A1 encodes a sodium-dependent phosphate cotransporter, and is widely expressed on the mammalian plasma membrane. In this study, we investigated the relationship between SLC20A1 and SLC activity.MethodsBy means of gene expression profiling, we studied the expressions of SLC20A1 in individuals with high SLC activity as compared to those with low SLC activity. In order to investigate the allelic association of SLC20A1 with SLC, we genotyped six tag single-nucleotide polymorphisms (tSNPs) in SLC20A1 in subjects from the Rochester Family Heart Study (RFHS) involving 1,815 individuals from 252 pedigrees of mixed European ancestry. The genetic association of SLC20A1 with SLC was assessed by Sequential Oligogenic Linkage Analysis Routines (SOLAR).ResultsExpression levels of SLC20A1 were higher in individuals with high SLC activity than in those with low SLC activity. Four SNPs in SLC20A1 were associated with SLC activity after adjusting for age, sex, body mass index, triglycerides, and antihypertensive drug treatment (P 0.05). The strongest evidence of association was in respect of rs4849091 (P = 0.001), and this association remained significant even after correction for multiple tests.ConclusionsAllelic variations in SLC20A1 were associated with the levels of SLC activity, thereby supporting the hypothesis that SLC20A1 is involved in determining SLC activity.

KW - blood pressure

KW - genetic association

KW - hypertension

KW - SLC20A1

KW - sodium-lithium countertransport

UR - http://www.scopus.com/inward/record.url?scp=80052970300&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80052970300&partnerID=8YFLogxK

U2 - 10.1038/ajh.2011.130

DO - 10.1038/ajh.2011.130

M3 - Article

VL - 24

SP - 1069

EP - 1072

JO - American Journal of Hypertension

JF - American Journal of Hypertension

SN - 0895-7061

IS - 10

ER -